vs
Kennedy-Wilson Holdings, Inc.（KW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Kennedy-Wilson Holdings, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$120.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -11.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-55.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.0%）
肯尼迪-威尔逊控股是一家房地产投资企业，公司总部位于美国加利福尼亚州比弗利山庄，业务覆盖全球多地房地产领域的投资与运营相关业务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KW vs PBYI — 直观对比
营收规模更大
KW
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出38.7%
-11.0%
自由现金流更多
PBYI
多$69.6M
$-55.2M
两年增速更快
PBYI
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.6M | $75.5M |
| 净利润 | $58.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 57.3% | 22.7% |
| 净利率 | 48.1% | — |
| 营收同比 | -11.0% | 27.7% |
| 净利润同比 | 32.7% | — |
| 每股收益（稀释后） | $0.22 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KWPBYI
| Q4 25 | $120.6M | $75.5M | ||
| Q3 25 | $116.4M | $54.5M | ||
| Q2 25 | $135.7M | $52.4M | ||
| Q1 25 | $128.3M | $46.0M | ||
| Q4 24 | $135.5M | $59.1M | ||
| Q3 24 | $127.5M | $80.5M | ||
| Q2 24 | $132.0M | $47.1M | ||
| Q1 24 | $136.4M | $43.8M |
净利润KWPBYI
| Q4 25 | $58.0M | — | ||
| Q3 25 | $-10.2M | $8.8M | ||
| Q2 25 | $5.6M | $5.9M | ||
| Q1 25 | $-29.6M | $3.0M | ||
| Q4 24 | $43.7M | — | ||
| Q3 24 | $-66.8M | $20.3M | ||
| Q2 24 | $-48.3M | $-4.5M | ||
| Q1 24 | $37.7M | $-4.8M |
毛利率KWPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率KWPBYI
| Q4 25 | 57.3% | 22.7% | ||
| Q3 25 | -6.2% | 17.6% | ||
| Q2 25 | 7.4% | 12.7% | ||
| Q1 25 | -26.9% | 8.7% | ||
| Q4 24 | 36.7% | 22.6% | ||
| Q3 24 | -60.8% | 27.4% | ||
| Q2 24 | -45.5% | -4.6% | ||
| Q1 24 | 47.2% | -5.3% |
净利率KWPBYI
| Q4 25 | 48.1% | — | ||
| Q3 25 | -8.8% | 16.2% | ||
| Q2 25 | 4.1% | 11.2% | ||
| Q1 25 | -23.1% | 6.5% | ||
| Q4 24 | 32.3% | — | ||
| Q3 24 | -52.4% | 25.2% | ||
| Q2 24 | -36.6% | -9.6% | ||
| Q1 24 | 27.6% | -11.0% |
每股收益（稀释后）KWPBYI
| Q4 25 | $0.22 | $0.26 | ||
| Q3 25 | $-0.15 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $0.24 | $0.40 | ||
| Q3 24 | $-0.56 | $0.41 | ||
| Q2 24 | $-0.43 | $-0.09 | ||
| Q1 24 | $0.19 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.5B | $130.3M |
| 总资产 | $6.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KWPBYI
| Q4 25 | $184.5M | $97.5M | ||
| Q3 25 | $382.6M | $94.4M | ||
| Q2 25 | $309.1M | $96.0M | ||
| Q1 25 | $356.6M | $93.2M | ||
| Q4 24 | $217.5M | $101.0M | ||
| Q3 24 | $367.1M | $96.7M | ||
| Q2 24 | $366.5M | $96.8M | ||
| Q1 24 | $541.9M | $107.2M |
总债务KWPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益KWPBYI
| Q4 25 | $1.5B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.6B | $104.7M | ||
| Q1 25 | $1.6B | $97.1M | ||
| Q4 24 | $1.6B | $92.1M | ||
| Q3 24 | $1.6B | $71.1M | ||
| Q2 24 | $1.7B | $48.5M | ||
| Q1 24 | $1.7B | $51.0M |
总资产KWPBYI
| Q4 25 | $6.6B | $216.3M | ||
| Q3 25 | $6.7B | $202.9M | ||
| Q2 25 | $6.8B | $194.9M | ||
| Q1 25 | $7.2B | $196.2M | ||
| Q4 24 | $7.0B | $213.3M | ||
| Q3 24 | $7.4B | $220.7M | ||
| Q2 24 | $7.5B | $205.0M | ||
| Q1 24 | $7.7B | $214.1M |
负债/权益比KWPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-55.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -45.8% | 19.1% |
| 资本支出强度资本支出/营收 | 55.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.20× | — |
| 过去12个月自由现金流最近4个季度 | $-103.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KWPBYI
| Q4 25 | $11.4M | $14.4M | ||
| Q3 25 | $-7.6M | $9.7M | ||
| Q2 25 | $42.0M | $14.1M | ||
| Q1 25 | $-51.9M | $3.6M | ||
| Q4 24 | $55.1M | $15.6M | ||
| Q3 24 | $-5.6M | $11.0M | ||
| Q2 24 | $36.7M | $1.0M | ||
| Q1 24 | $-5.6M | $11.2M |
自由现金流KWPBYI
| Q4 25 | $-55.2M | $14.4M | ||
| Q3 25 | $-18.0M | $9.7M | ||
| Q2 25 | $29.4M | $14.1M | ||
| Q1 25 | $-59.7M | $3.6M | ||
| Q4 24 | $-76.5M | $15.6M | ||
| Q3 24 | $-27.7M | $11.0M | ||
| Q2 24 | $-500.0K | $1.0M | ||
| Q1 24 | $-57.1M | — |
自由现金流率KWPBYI
| Q4 25 | -45.8% | 19.1% | ||
| Q3 25 | -15.5% | 17.7% | ||
| Q2 25 | 21.7% | 26.8% | ||
| Q1 25 | -46.5% | 7.7% | ||
| Q4 24 | -56.5% | 26.4% | ||
| Q3 24 | -21.7% | 13.7% | ||
| Q2 24 | -0.4% | 2.1% | ||
| Q1 24 | -41.9% | — |
资本支出强度KWPBYI
| Q4 25 | 55.2% | 0.0% | ||
| Q3 25 | 8.9% | 0.0% | ||
| Q2 25 | 9.3% | 0.0% | ||
| Q1 25 | 6.1% | 0.1% | ||
| Q4 24 | 97.1% | 0.0% | ||
| Q3 24 | 17.3% | 0.0% | ||
| Q2 24 | 28.2% | 0.0% | ||
| Q1 24 | 37.8% | 0.0% |
现金转化率KWPBYI
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 7.50× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
PBYI
暂无分部数据
